Dopamine Receptor Heteromers: Biasing Antipsychotics

Future Medicinal Chemistry - United Kingdom
doi 10.4155/fmc-2018-0335
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Future Science Ltd

Related search

Dopamine D4 Receptor, but Not the ADHD-associated D4.7 Variant, Forms Functional Heteromers With the Dopamine D2S Receptor in the Brain

Molecular Psychiatry
PsychiatryMolecular NeuroscienceMental HealthMolecular BiologyCellular
2011English

How Do Antipsychotics Exert Their Effects on Dopamine Receptor Subtypes?

Folia Pharmacologica Japonica
Pharmacology
1998English

D1-mGlu5 Heteromers Mediate Noncanonical Dopamine Signaling in Parkinson’s Disease

Journal of Clinical Investigation
Medicine
2020English

Antagonism of Dopamine D2 Receptor/ -Arrestin 2 Interaction Is a Common Property of Clinically Effective Antipsychotics

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2008English

Typical and Atypical Antipsychotics Do Not Differ Markedly in Their Reversibility of Antagonism of the Dopamine D2 Receptor

International Journal of Neuropsychopharmacology
PsychiatryMental HealthPharmacology
2013English

Beta-Arrestin1 Prevents Preeclampsia by Downregulation of Mechanosensitive AT1-B2 Receptor Heteromers

Cell
BiochemistryGeneticsMolecular Biology
2019English

Opioid–galanin Receptor Heteromers Differentiate the Dopaminergic Effects of Morphine and Methadone

Journal of Clinical Investigation
Medicine
2019English

Biasing Effects of Receptor-Ligand Complexes on Protein-Unfolding Statistics

Physical review. E
Nonlinear PhysicsProbabilityStatisticsCondensed Matter PhysicsStatistical
2016English

New Dopamine Receptor Stimulant Drug

Cellular and Molecular Life Sciences
Molecular NeuroscienceMolecular MedicineCell BiologyMolecular BiologyPharmacologyCellular
1972English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy